Christine Sarkisian will be retiring this week from her position as Trade Commissioner, Life Sciences Business Development. For nearly 30 years at the Consulate General of Canada in Boston she has been instrumental in working with and helping Canadian entrepreneurs on their path to commercialization.

With more than $150,000 in prizes, TELUS Pitch is Canada’s largest small business competition. Finalist companies will be narrowed to a list of 10 by public voting, which is now open.

Winterlight Labs announced it is developing vocal biomarkers for monitoring disease progression in frontotemporal dementia patients in collaboration with Alector, a biotechnology company developing therapeutics for neurodegeneration.

ANGLE PLC raised $30M from new and existing investors to commercialize its Parsortix liquid biopsy for ovarian cancer as well as to support its filing with the US Food and Drug Administration.

Exact Imaging announced that it is the proud recipient of Frost & Sullivan’s 2019 Global Prostate Cancer Diagnostic Imaging Technology Innovation Award for their ExactVu™ Micro-Ultrasound System.

The CIX TOP programs are Canada’s largest national showcase of the hottest and most innovative tech companies. Apply for the chance to be showcased at the 2019 CIX Summit.

Gairdner offers significant funding and support to bring the world’s best health scientists to Canada to address the newest discoveries and most pressing issues in biomedical research.

The Creative Destruction Lab is now accepting applications from startups for its 2019/20 seed-stage program for founders pursuing commercial opportunities predicated on translational science and technology innovations that improve human health and wellness.

Canada’s brightest innovators will converge in the CNE Innovation Garage over the fair's middle weekend to pitch their cutting edge inventions and compete for prize money up to $25,000 and in-kind services.

The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities.

Vena Medical was accepted into the Ontario Brain Institute's ONtrepreneur program, which provides an investment of $50,000 as well as 12 months of training opportunities, one-on-one mentorship and communications support.

Hosted by RBC in partnership with the Rick Hansen Institute, eight shortlisted international and Canadian startups that develop spinal cord injury products pitched their businesses to a panel of corporate and scientific experts, with Braze Mobility winning first place.

MedTech Innovator announced Flosonics Medical as one of 50 companies selected to participate in the organization’s flagship four-month program, which will offer access to leading manufacturers, providers, investors, and other industry stakeholders.

The Medical Innovation Xchange is Canada's first industry-led hub dedicated to supporting southern Ontario medtech start-ups achieve global scale while keeping their headquarters in Waterloo Region, and will house anchor tenant Intellijoint Surgical who will be joined by Penta Medical, Vena Medical, and Bloom Care Solutions.

Spiderwort announced the raise of $500,000 CAD as part of its oversubscribed Friends and Family round, along with naming new advisory board members.

The Export Business Services Branch (EBSB), Ontario Ministry of Economic Development, Job Creation and Trade, is organizing a Trade Mission to attend the AdvaMed MedTech Conference in order to facilitate introductions for Ontario companies to potential customers, partners and investors.

The Canadian Technology Accelerator (CTA) initiative helps Canadian companies with an existing technology, product or service explore opportunities in foreign markets. Life Science sector sessions run in Boston, San Francisco, and Singapore.

This Partnership Development Activity mission will focus on introducing Canadian SMEs to potential Brazilian partners for industrial R&D collaboration specific to nanotechnology with applications to the biotechnology, medicine, pharmaceuticals and cosmetics sectors.

Thornhill Medical's investigative tool RespirAct™ Gas Control System contributed to international team led by scientists from Lawson Health Research Institute and Cedars-Sinai Medical Center.